Deborah Morosini's most recent trade in Prelude Therapeutics Inc was a trade of 90,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.85 per share. | 16 Nov 2021 | 28,751 | 29,195 | - | 12.8 | 369,450 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 28,751 | 196,045 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Sale of securities on an exchange or to another person at price $ 15.87 per share. | 16 Nov 2021 | 28,351 | 844 | - | 15.9 | 449,962 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Sale of securities on an exchange or to another person at price $ 16.42 per share. | 16 Nov 2021 | 400 | 444 | - | 16.4 | 6,570 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2021 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Sale of securities on an exchange or to another person at price $ 40.29 per share. | 29 Apr 2021 | 3,223 | 444 | - | 40.3 | 129,853 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 3,223 | 4,323 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 29 Apr 2021 | 3,223 | 3,667 | - | 1.9 | 6,091 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 08 Apr 2021 | 100 | 544 | - | 1.9 | 189 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 08 Apr 2021 | 100 | 444 | - | 40 | 4,000 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 100 | 7,546 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Sale of securities on an exchange or to another person at price $ 40.04 per share. | 07 Apr 2021 | 1,000 | 444 | - | 40.0 | 40,043 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.89 per share. | 07 Apr 2021 | 1,000 | 1,444 | - | 1.9 | 1,890 | Common Stock |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 1,000 | 7,646 | - | - | Employee Stock Option (right to buy) | |
| Prelude Therapeutics Inc | Deborah Morosini | EVP, Chief of Clinical Affairs | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 29 Sep 2020 | 444 | 444 | - | 19 | 8,436 | Common Stock |